Imatinib mesylate in the treatment of gastrointestinal stromal tumor related adverse reaction and prevention strategies
10.3760/cma.j.issn.1673-4203.2015.07.018
- VernacularTitle:甲磺酸伊马替尼治疗胃肠道间质瘤的相关不良反应及防治策略
- Author:
Jianwei CHEN
;
Zaizhong ZHANG
;
Lie WANG
- Publication Type:Journal Article
- Keywords:
Stomach neoplasms;
Adverse effects;
Preventive strategy;
Treatment outcome
- From:
International Journal of Surgery
2015;42(7):488-493
- CountryChina
- Language:Chinese
-
Abstract:
Molecular targeted therapy is a treatment bed emerging recent years for the treatment of malignant tumors,imatinib mesylate in the treatment of gastrointestinal stromal tumor (GIST) is a successful example ofmolecular targeted therapy.Imatinib mesylate can inhibit tyrosine kinase andinhibition of cell proliferation by treatment of gastrointestinal stromal tumor.With the positive effect of imatinib in the treatment of GIST,the related adverse reactions and the prevention and treatment strategies are worth to be discussed.
